metricas
covid
Buscar en
Revista Española de Geriatría y Gerontología
Toda la web
Inicio Revista Española de Geriatría y Gerontología Valoración de la producción nocturna del catabolito de melatonina, 6-sulfatoxi...
Journal Information
Vol. 39. Issue 3.
Pages 160-165 (January 2004)
Share
Share
Download PDF
More article options
Vol. 39. Issue 3.
Pages 160-165 (January 2004)
Full text access
Valoración de la producción nocturna del catabolito de melatonina, 6-sulfatoximelatonina, durante el climaterio
Evaluation of nocturnal excretion of 6-sulfatoximelatonin during menopause
Visits
5963
B. Díaz-Lópeza,
Corresponding author
beatrizd@uniovi.es

Correspondencia: Departamento de Biología Funcional. Área de Fisiología. Facultad de Medicina. Universidad de Oviedo. Julián Clavería, 6. 33006 Oviedo. España.
, N. Vázquez-Morenoa, P. Llanezab
a Departamento de Biología Funcional. Área de Fisiología. Facultad de Medicina. Universidad de Oviedo. Oviedo
b Servicio de Menopausia. Hospital Central de Asturias. Universidad de Oviedo. Oviedo. España
This item has received
Article information
Introducción

durante el envejecimiento del eje reproductor femenino, el climaterio, el agotamiento folicular en los ovarios origina cambios hormonales entre los cuales se encuentra la melatonina. Sin embargo, el conocimiento de las interacciones entre dichos parámetros dista mucho de ser profundo.

Objetivo

valorar el ritmo nocturno de producción de melatonina por medio de la excreción urinaria de 6-sulfatoximelatonina (6-SMEL).

Pacientes y método

se realizó un estudio entre 27 mujeres que acudían a las consultas de Ginecología y Menopausia del Hospital Central de Asturias, con una edad de 43-60 años, sanas y sin ningún tipo de tratamiento excepto la terapia hormonal sustitutiva. Ninguna había tenido menopausia quirúrgica. La noche anterior a la correspondiente visita ginecológica recogieron muestras de orina a las siguientes horas: 22:00, 24:00, 04:00, 08:00 y 10:00.

Resultados

el estudio del ritmo nocturno de producción de 6-SMEL mostró en el grupo de mujeres menopáusicas el valor más bajo a las 22:00 h, de 475 pg/ml, y el más elevado a las 08:00 h, de 6.063,33 pg/ml, con diferencias estadísticamente significativas: p < 0,01; p < 0,05 a las 22:00 h frente a las 10:00, 04:00 y 08:00 h. En el grupo de menopáusicas que recibían terapia hormonal sustitutiva, el valor más bajo se obtuvo a las 22:00 h, 385 pg/ml, y el valor pico a las 08:00 h, 8.560 pg/ml, con diferencias estadísticamente significativas: p < 0,01 a las 22:00 frente a las 24:00 h; p < 0,05 a las 08:00 frente a las 22:00, 24:00 y 10:00 h. En el grupo de perimenopausia no se demostró estadísticamente un valor pico a ninguna de las horas estudiadas.

Conclusión

la terapia hormonal sustitutiva influyó sobre el ritmo nocturno de secreción de 6-SMEL, pero la cantidad total excretada no resultó afectada durante el climaterio.

Palabras clave:
Menopausia
Perimenopausia
6-sulfatoximelatonina
Tratamiento hormona sustitutivo
Introduction

during ageing of the female reproductive axis and menopause, alteration in melatonin levels is one of the hormonal changes that occurs due to follicular ovarian exhaustion. However, the interaction between these parameters is far from clearly defined.

Objective

to evaluate nocturnal melatonin rhythm through urinary 6-sulphatoximelatonin (6-SMEL) excretion.

Patients and method

a study was performed with 27 women who attended the Gynaecology and Menopause Service of the Central Hospital of Asturias (Spain). The women were aged between 43 and 60 years. All the women were healthy and were taking no treatment except hormone replacement therapy (HRT). None of the women had had surgical menopause. The night before the gynecologic evaluation, urine samples were collected at 22:00, 24:00, 04:00, 08:00 and 10:00 hours.

Results

nocturnal 6-SMEL rhythm in menopausal women showed the lowest value at 22:00 h (475 pg/ml) and the highest value at 08:00 (6063,33 pg/ml) with statistically significant differences: p < 0.01; p < 0.05 at 22:00 vs. 10:00, 04:00 and 08:00 h. In menopausal women taking HRT the lowest value was again observed at 22:00 h (385 pg/ml), and the peak value was observed at 08:00 h (8560 pg/ml) with statistically significant differences: p < 0.01, 22:00 vs. 24:00 h; p < 0.05, 08:00 vs. 22:00, 24:00 and 10:00 h. In the perimenopausal group no peak value was observed at any of the times studied.

Conclusion

the nocturnal secretion rhythm of 6-SMEL was influenced by HRT. No differences in the total amount of 6-SMEL excreted during menopause were found.

Key words:
Menopause
Perimenopause
6-Sulphatoximelatonin
Hormone replacement therapy
Full text is only aviable in PDF
Bibliografía
[1.]
R.J. Reiter.
Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals.
J Neural Transm Suppl, 21 (1986), pp. 35-54
[2.]
D.C. Klein, J.R. Weller.
Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase.
Science, 169 (1970), pp. 1093-1095
[3.]
R.J. Reiter.
Neuroendocrine effects of light.
Int J Biometerol, 35 (1991), pp. 169-175
[4.]
A. Conti, G.J. Maestronin.
The clinical neuroimmunotherapeutic role of melatonin in oncology.
J Pineal Res, 19 (1995), pp. 103-110
[5.]
G.J. Maestroni, A. Conti, W. Pierpaoli.
Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect to corticosterone.
J Neuroimmunol, 13 (1986), pp. 19-30
[6.]
M. Wilkinson, J. Arendt, J. Bradtke, D. De Ziegler.
Determination of a darkinduced increase of pineal N-acetyl transferase activity and simultaneous radioimmunoassay of melatoninin pineal, serum and pituitary tissue of the male rat.
J Endocrinol, 72 (1977), pp. 243-244
[7.]
M. Tetsuo, M. Poth, S.P. Markey.
Melatonin metabolite excretion during childhood and puberty.
J Clin Endocrinol Metab, 55 (1982), pp. 311-313
[8.]
K. Rager, I. Kozak, D. Gupta, A. Attanasio.
6-hydroxymelatonin sulfate excretion in children from newborn age to adulthood.
Adv Pineal Res, 3 (1989), pp. 299-304
[9.]
I. Haimov, M. Laudon, N. Zisapel, M. Souroujon, D. Nof, A. Shlitner, et al.
Sleep disorders and melatonin rhythms in elderly people.
BMJ, 309 (1994), pp. 167
[10.]
D. Garfinkel, M. Laudon, D. Nof, N. Zisapel.
Improvement of sleep quality in elderly people by controlled-release melatonin.
Lancet, 346 (1995), pp. 541-544
[11.]
C. Graham, M.R. Cook, R. Kavet, A. Sastre, D.K. Smith.
Prediction of nocturnal plasma melatonin from morning urinary measures.
J Pineal Res, 24 (1998), pp. 230-238
[12.]
N. Avis, S. McKinlay.
A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study.
Maturitas, 13 (1991), pp. 65-79
[13.]
J. Cuadros, P. Llaneza, S. Mateu.
Demografía y epidemiología del climaterio en España. En: Libro blanco de la menopausia en España.
[14.]
L. Speroff, R. Glass, N. Kase.
Clinical gynecologic endocrinology and infertility.
[15.]
D.P. Cardinali, C.A. Nagle, J.M. Rosner.
Control of estrogen and androgen receptors in the rat pineal gland by catecholamine transmitter.
Life Sci, 16 (1975), pp. 93-106
[16.]
D.P. Cardinali, C.A. Nagle, J.M. Rosner.
Effects of estradiol on melatonin and protein synthesis in the rat pineal organ.
Horm Res, 5 (1974), pp. 304-310
[17.]
J. Arendt, C.A. Laud, A.M. Symons, S.J. Pryde.
Plasma melatonin in ewes after ovariectomy.
J Reprod Fertil, 68 (1983), pp. 213-218
[18.]
F. Waldhauser, G. Weiszenbacher, E. Tatzer, B. Gisinger, M. Waldhauser, M. Schemper.
Alterations in nocturnal serum melatonin levels in humans with growth and aging.
J Clin Endocrinol Metab, 66 (1988), pp. 648-652
[19.]
S.L. Berga, J.F. Mortola, S.S. Yen.
Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea.
J Clinical Endocrinol Metab, 66 (1988), pp. 242-244
[20.]
G.A. Laughlin, A.B. Loucks, S.S. Yent.
Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: unaltered by opioidergic or dopaminergic blockade.
J Clin Endocrinol Metab, 73 (1991), pp. 1321-1326
[21.]
M.R. Cook, C. Graham, R. Kavet, R.G. Stevens, S. Davis, L. Kheifets.
Morning urinary assessment of nocturnal melatonin secretion in older women.
J Pineal Res, 28 (2000), pp. 41-47
[22.]
W. Blaicher, E. Speck, M.H. Imhof, D.M. Gruber, C. Schneeberger, M.O. Sator, et al.
Melatonin in postmenopausal females.
Arch Gynecol Obstet, 263 (2000), pp. 116-118
Copyright © 2004. Sociedad Española de Geriatría y Gerontología
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos